Key facts
- Notable investors include Kiwoom Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MS BIO
- ·The full record, as it builds
Funding rounds
No funding rounds for MS BIO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MS BIO
Developer of biomedical and life science products designed for research, development, and clinical use. The company's platform integrates in-house research and development, collaboration with clinical experts and corporate partners, product design and validation processes, regulated manufacturing capabilities, and multiple research and production facilities, enabling healthcare providers, researchers, and industry partners to develop, test, produce, and distribute medical and life science services that support clinical practice, operational reliability, and patient health outcomes.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2015
- Website
- msbio.co.kr/
- Ownership
- Privately Held (backing)
MS BIO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MS BIO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MS BIO in its N-PORT filings yet. We sweep new filings monthly.